Novo CEO pressed by Senate to chop charges of being overweight, diabetic issues medications CEO Lars Fruergaard Jørgensen advised lawmakers the corporate would consider new talks with insurers regarding the record charges of Wegovy and copyright when they pledge to help keep the medicines on their formularies. Where by are https://aya-healthcare-address94938.blog2learn.com/78622143/everything-about-healthcare-news